Stocks to Watch Tomorrow 12/21
Research In Motion (Nasdaq: RIMM) will be reporting after the close tomorrow. Expect the stock to be volatile before and after the report. Many are expecting a strong quarter due to sales of the new BlackBerry Pearl. Competitor Palm reported yesterday, beating lowered Q2 results, but guiding below for Q3. Many think RIMM is stealing market share from PALM, but there are also a handful of new competitors making similar products which could stymie growth.
Micron Technology Inc. (NYSE: MU) and Red Hat Inc. (NYSE: RHT) are also on deck to report earnings after the close tomorrow and will be ones to watch.
Micro-caps Mamma.com Inc. (Nasdaq: MAMA) (+33.4%) and Escala Group Inc. (Nasdaq: ESCL) (+22%) continue to kill the shorts. Their runs will likely end soon, but they could continue higher in the near term on the squeeze.
SIGA Technologies Inc. (Nasdaq: SIGA) jammed 82% higher in the final hours of trading after the company said it was given Orphan Drug for its smallpox drug, SIGA-246. Orphan Drug designation gives SIGA 7 years of marketing exclusivity in the US if the drug becomes the first of its kind to obtain marketing approval from the FDA.
The IPO for Artes Medical, Inc. (Nasdaq: ARTE) had a nice day, climbing 27.8% above the $6 pricing. The stock priced at the low end of the $6.00-$8.00 range, but originally was supposed to come to the market at $12-$14. The company markets an aesthetic injectable implant for the correction of facial wrinkles.
Northfield Laboratories Inc. (Nasdaq: NFLD) sunk 57% today after yesterday's 20% haircut following negative news on PolyHeme, its controversial red blood cell substitute. As old money calls it quits and moves on, some new money may be bottom fishing. This looks like a perfect situation for an activist fund to get involved with. Dan Loeb are you out there?
Sally Beauty Holdings Inc. (NYSE: SBH) was slammed to the tune of 13% today after losing L'Oreal rights. We may see bottom fishing in the name in the near term. Sally Beauty was spun-off from Alberto-Culver Co. (NYSE: ACV) in November.
Micron Technology Inc. (NYSE: MU) and Red Hat Inc. (NYSE: RHT) are also on deck to report earnings after the close tomorrow and will be ones to watch.
Micro-caps Mamma.com Inc. (Nasdaq: MAMA) (+33.4%) and Escala Group Inc. (Nasdaq: ESCL) (+22%) continue to kill the shorts. Their runs will likely end soon, but they could continue higher in the near term on the squeeze.
SIGA Technologies Inc. (Nasdaq: SIGA) jammed 82% higher in the final hours of trading after the company said it was given Orphan Drug for its smallpox drug, SIGA-246. Orphan Drug designation gives SIGA 7 years of marketing exclusivity in the US if the drug becomes the first of its kind to obtain marketing approval from the FDA.
The IPO for Artes Medical, Inc. (Nasdaq: ARTE) had a nice day, climbing 27.8% above the $6 pricing. The stock priced at the low end of the $6.00-$8.00 range, but originally was supposed to come to the market at $12-$14. The company markets an aesthetic injectable implant for the correction of facial wrinkles.
Northfield Laboratories Inc. (Nasdaq: NFLD) sunk 57% today after yesterday's 20% haircut following negative news on PolyHeme, its controversial red blood cell substitute. As old money calls it quits and moves on, some new money may be bottom fishing. This looks like a perfect situation for an activist fund to get involved with. Dan Loeb are you out there?
Sally Beauty Holdings Inc. (NYSE: SBH) was slammed to the tune of 13% today after losing L'Oreal rights. We may see bottom fishing in the name in the near term. Sally Beauty was spun-off from Alberto-Culver Co. (NYSE: ACV) in November.
Labels: ARTE, Escala Group, ESCL, MAMA, Mamma.com, Micron, MU, NFLD, Red Hat, Research In Motion, RHT, RIMM, Sally Beauty, SBH, SIGA
posted by Lon @ 5:03 PM
1 Comments:
At 11:32 PM,
Trading Goddess said…
I confess to bottom fishing!
Post a Comment
<< Home